Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine as Adjuvant Treatment in Acute Organophosphorus Poisoning
NCT05927259Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of acetylcysteine in organophosphate poisoning (2 arms), sponsored by Ain Shams University. Primary endpoint: Mortality at 72 hours. Started Jan 2022; status: completed.
02
Drugs
acetylcysteine
03
Conditions
organophosphate poisoning
Beyond the preview
Go deeper on NCT05927259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05927259.